Weiss Asset Management LP Purchases Shares of 28,328 Danaher Co. (NYSE:DHR)

Weiss Asset Management LP purchased a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 28,328 shares of the conglomerate's stock, valued at approximately $7,876,000.

Other institutional investors also recently modified their holdings of the company. Fort Pitt Capital Group LLC lifted its position in Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock valued at $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC purchased a new position in shares of Danaher in the 3rd quarter worth approximately $217,000. Oak Thistle LLC bought a new stake in Danaher in the second quarter worth about $363,000. Harvest Portfolios Group Inc. increased its stake in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock worth $56,233,000 after buying an additional 2,465 shares during the period. Finally, Diversified Trust Co boosted its holdings in shares of Danaher by 75.4% in the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after purchasing an additional 1,874 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR traded up $2.25 during trading on Friday, reaching $230.12. The stock had a trading volume of 3,060,478 shares, compared to its average volume of 2,776,154. The business has a fifty day moving average price of $251.66 and a 200-day moving average price of $258.69. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $166.21 billion, a PE ratio of 43.97, a PEG ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. The company's quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher's dividend payout ratio is currently 20.61%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DHR. Royal Bank of Canada reduced their price target on shares of Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Barclays reduced their target price on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 23rd. Evercore ISI increased their price objective on Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Stifel Nicolaus increased their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a report on Wednesday, October 23rd. Finally, StockNews.com downgraded shares of Danaher from a "buy" rating to a "hold" rating in a report on Thursday. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.